71 related articles for article (PubMed ID: 17135457)
1. Early Intravenous Magnesium Sulfate and Its Impact on Cerebral Vasospasm as well as Delayed Cerebral Ischemia in Aneurysmal Subarachnoid Hemorrhage: A Retrospective Matched Case-Control Analysis.
Feulner J; Weidinger CS; Dörfler A; Birkholz T; Buchfelder M; Sommer B
World Neurosurg; 2024 Jun; 186():e106-e113. PubMed ID: 38514031
[TBL] [Abstract][Full Text] [Related]
2. Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.
Wipplinger C; Cattaneo A; Wipplinger TM; Lamllari K; Semmler F; Geske C; Messinger J; Nickl V; Beez A; Ernestus RI; Pham M; Westermaier T; Weiland J; Stetter C; Kunze E
Neurosurg Rev; 2023 Sep; 46(1):256. PubMed ID: 37751032
[TBL] [Abstract][Full Text] [Related]
3. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis.
Wong GK; Boet R; Poon WS; Chan MT; Gin T; Ng SC; Zee BC
Crit Care; 2011; 15(1):R52. PubMed ID: 21299874
[TBL] [Abstract][Full Text] [Related]
4. Prevention of delayed cerebral ischaemia after subarachnoid haemorrhage.
Al-Shahi R; Robson M
J Neurol Neurosurg Psychiatry; 2006 Dec; 77(12):1300-1. PubMed ID: 17110743
[TBL] [Abstract][Full Text] [Related]
5. Letter to editor: Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: A retrospective evaluation of a 12-year single-center experience.
Sohail K; Zaidi SMF
Neurosurg Rev; 2024 Apr; 47(1):193. PubMed ID: 38662220
[TBL] [Abstract][Full Text] [Related]
6. A letter to the editor: Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.
Sun Y; Zhao H; An Y
Neurosurg Rev; 2023 Oct; 46(1):273. PubMed ID: 37845559
[No Abstract] [Full Text] [Related]
7. The Socioeconomic Distressed Communities Index Predicts 90-Day Mortality Among Intracranial Tumor Patients.
Chakravarti S; Kuo CC; Oak A; Ranganathan S; Jimenez AE; Kazemi F; Saint-Germain MA; Gallia G; Rincon-Torroella J; Jackson C; Bettegowda C; Mukherjee D
World Neurosurg; 2024 Jun; 186():e552-e565. PubMed ID: 38599377
[TBL] [Abstract][Full Text] [Related]
8. Effects of intravenous infusion of hydrogen-rich fluid combined with intra-cisternal infusion of magnesium sulfate in severe aneurysmal subarachnoid hemorrhage: study protocol for a randomized controlled trial.
Takeuchi S; Mori K; Arimoto H; Fujii K; Nagatani K; Tomura S; Otani N; Osada H; Wada K
BMC Neurol; 2014 Sep; 14():176. PubMed ID: 25201463
[TBL] [Abstract][Full Text] [Related]
9. Magnesium in aneurysmal subarachnoid hemorrhage (MASH II) phase III clinical trial MASH-II study group.
Dorhout Mees SM;
Int J Stroke; 2008 Feb; 3(1):63-5. PubMed ID: 18705917
[TBL] [Abstract][Full Text] [Related]
10. A contemporary review of therapeutic and regenerative management of intracerebral hemorrhage.
Sadaf H; Desai VR; Misra V; Golanov E; Hegde ML; Villapol S; Karmonik C; Regnier-Golanov A; Sayenko D; Horner PJ; Krencik R; Weng YL; Vahidy FS; Britz GW
Ann Clin Transl Neurol; 2021 Nov; 8(11):2211-2221. PubMed ID: 34647437
[TBL] [Abstract][Full Text] [Related]
11. Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage.
Cho WS; Kim JE; Park SQ; Ko JK; Kim DW; Park JC; Yeon JY; Chung SY; Chung J; Joo SP; Hwang G; Kim DY; Chang WH; Choi KS; Lee SH; Sheen SH; Kang HS; Kim BM; Bae HJ; Oh CW; Park HS; ; ; ;
J Korean Neurosurg Soc; 2018 Mar; 61(2):127-166. PubMed ID: 29526058
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the anti-inflammatory effects of peri-operative infusion of magnesium sulfate on the microsurgical procedures for intracranial tumors.
Etezadi F; Aklamli M; Najafi A; Khajavi M; Shariat Moharari R; Mirrahimi B; Mortazavi SA; Mojtahedzadeh M
Anesth Pain Med; 2014 Dec; 4(5):e22379. PubMed ID: 25798379
[TBL] [Abstract][Full Text] [Related]
13. The role of magnesium in the management of cerebral vasospasm.
Odom MJ; Zuckerman SL; Mocco J
Neurol Res Int; 2013; 2013():943914. PubMed ID: 23766903
[TBL] [Abstract][Full Text] [Related]
14. Effect of magnesium sulfate therapy on patients with aneurysmal subarachnoid hemorrhage using serum S100B protein as a prognostic marker.
Hassan T; Nassar M; Elhadi SM; Radi WK
Neurosurg Rev; 2012 Jul; 35(3):421-7; discussion 427. PubMed ID: 22170177
[TBL] [Abstract][Full Text] [Related]
15. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage.
Dorhout Mees SM; van den Bergh WM; Algra A; Rinkel GJ
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):729-31. PubMed ID: 17135457
[TBL] [Abstract][Full Text] [Related]
16. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial.
van den Bergh WM; Algra A; van Kooten F; Dirven CM; van Gijn J; Vermeulen M; Rinkel GJ;
Stroke; 2005 May; 36(5):1011-5. PubMed ID: 15790946
[TBL] [Abstract][Full Text] [Related]
17. Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage.
Van de Water JM; Van den Bergh WM; Hoff RG; Algra A; Rinkel GJ
Magnes Res; 2007 Jun; 20(2):130-5. PubMed ID: 18062586
[TBL] [Abstract][Full Text] [Related]
18. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment.
van den Bergh WM; Albrecht KW; Berkelbach van der Sprenkel JW; Rinkel GJ
Acta Neurochir (Wien); 2003 Mar; 145(3):195-9; discussion 199. PubMed ID: 12632115
[TBL] [Abstract][Full Text] [Related]
19. Magnesium sulphate for aneurysmal subarachnoid hemorrhage: why, how, and current controversy.
Wong GK; Poon WS
Acta Neurochir Suppl; 2013; 115():45-8. PubMed ID: 22890642
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
